| Steven D Picerne, MD | |
|
1800 W Hibiscus Blvd Ste 100, Melbourne, FL 32901-2624 | |
| (321) 726-3800 | |
| Not Available |
| Full Name | Steven D Picerne |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 34 Years |
| Location | 1800 W Hibiscus Blvd Ste 100, Melbourne, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124046339 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 043914 (Connecticut) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | ME84506 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Technology Transfer Corporation | 1658265079 | 7 |
News Archive
A new pilot study by US researchers demonstrates an alternative approach to long-lasting disinfection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by using cationic phenylene ethynylene polymers and oligomers (i.e., conjugated electrolytes). The paper is currently available on medRxiv* preprint server.
Seattle Genetics, Inc. today announced that its phase IIb clinical trial of lintuzumab (SGN-33) in older patients with acute myeloid leukemia (AML) did not meet its primary endpoint of extending overall survival. Lintuzumab is a naked monoclonal antibody that targets the CD33 antigen. As a result of the outcome of this trial, the company will discontinue its development program for lintuzumab.
From a corner office high atop CHI Health Immanuel, a longtime Creighton University researcher is plotting another step along a road he hopes will eventually free diabetic women from osteoporosis, one of many diseases that strike diabetics more forcefully than the general population.
Young persons who use alcohol and/or marijuana experience heightened likelihood of condomless sex, according to a new study published in The American Journal on Addictions. This increased likelihood was greater for women than for men on days with alcohol or marijuana use, each alone but especially when combined.
Merck, known as MSD outside the United States and Canada, announced today that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) unanimously voted to recommend approval of Merck's VYTORIN (ezetimibe/simvastatin) for use in patients with pre-dialysis chronic kidney disease.
› Verified 5 days ago
| Entity Name | Medical Technology Transfer Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104947217 PECOS PAC ID: 1658265079 Enrollment ID: O20040209000360 |
News Archive
A new pilot study by US researchers demonstrates an alternative approach to long-lasting disinfection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by using cationic phenylene ethynylene polymers and oligomers (i.e., conjugated electrolytes). The paper is currently available on medRxiv* preprint server.
Seattle Genetics, Inc. today announced that its phase IIb clinical trial of lintuzumab (SGN-33) in older patients with acute myeloid leukemia (AML) did not meet its primary endpoint of extending overall survival. Lintuzumab is a naked monoclonal antibody that targets the CD33 antigen. As a result of the outcome of this trial, the company will discontinue its development program for lintuzumab.
From a corner office high atop CHI Health Immanuel, a longtime Creighton University researcher is plotting another step along a road he hopes will eventually free diabetic women from osteoporosis, one of many diseases that strike diabetics more forcefully than the general population.
Young persons who use alcohol and/or marijuana experience heightened likelihood of condomless sex, according to a new study published in The American Journal on Addictions. This increased likelihood was greater for women than for men on days with alcohol or marijuana use, each alone but especially when combined.
Merck, known as MSD outside the United States and Canada, announced today that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) unanimously voted to recommend approval of Merck's VYTORIN (ezetimibe/simvastatin) for use in patients with pre-dialysis chronic kidney disease.
› Verified 5 days ago
| Entity Name | Symphony Diagnostic Services No 1 Llc |
|---|---|
| Entity Type | Part B Supplier - Portable X-ray Supplier |
| Entity Identifiers | NPI Number: 1700865094 PECOS PAC ID: 5193638765 Enrollment ID: O20060913000187 |
News Archive
A new pilot study by US researchers demonstrates an alternative approach to long-lasting disinfection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by using cationic phenylene ethynylene polymers and oligomers (i.e., conjugated electrolytes). The paper is currently available on medRxiv* preprint server.
Seattle Genetics, Inc. today announced that its phase IIb clinical trial of lintuzumab (SGN-33) in older patients with acute myeloid leukemia (AML) did not meet its primary endpoint of extending overall survival. Lintuzumab is a naked monoclonal antibody that targets the CD33 antigen. As a result of the outcome of this trial, the company will discontinue its development program for lintuzumab.
From a corner office high atop CHI Health Immanuel, a longtime Creighton University researcher is plotting another step along a road he hopes will eventually free diabetic women from osteoporosis, one of many diseases that strike diabetics more forcefully than the general population.
Young persons who use alcohol and/or marijuana experience heightened likelihood of condomless sex, according to a new study published in The American Journal on Addictions. This increased likelihood was greater for women than for men on days with alcohol or marijuana use, each alone but especially when combined.
Merck, known as MSD outside the United States and Canada, announced today that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) unanimously voted to recommend approval of Merck's VYTORIN (ezetimibe/simvastatin) for use in patients with pre-dialysis chronic kidney disease.
› Verified 5 days ago
| Entity Name | Community Mobile Diagnostics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023104007 PECOS PAC ID: 4789610643 Enrollment ID: O20161004002024 |
News Archive
A new pilot study by US researchers demonstrates an alternative approach to long-lasting disinfection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by using cationic phenylene ethynylene polymers and oligomers (i.e., conjugated electrolytes). The paper is currently available on medRxiv* preprint server.
Seattle Genetics, Inc. today announced that its phase IIb clinical trial of lintuzumab (SGN-33) in older patients with acute myeloid leukemia (AML) did not meet its primary endpoint of extending overall survival. Lintuzumab is a naked monoclonal antibody that targets the CD33 antigen. As a result of the outcome of this trial, the company will discontinue its development program for lintuzumab.
From a corner office high atop CHI Health Immanuel, a longtime Creighton University researcher is plotting another step along a road he hopes will eventually free diabetic women from osteoporosis, one of many diseases that strike diabetics more forcefully than the general population.
Young persons who use alcohol and/or marijuana experience heightened likelihood of condomless sex, according to a new study published in The American Journal on Addictions. This increased likelihood was greater for women than for men on days with alcohol or marijuana use, each alone but especially when combined.
Merck, known as MSD outside the United States and Canada, announced today that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) unanimously voted to recommend approval of Merck's VYTORIN (ezetimibe/simvastatin) for use in patients with pre-dialysis chronic kidney disease.
› Verified 5 days ago
| Entity Name | Community Mobile Ultrasound Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760620959 PECOS PAC ID: 4183761893 Enrollment ID: O20170407000173 |
News Archive
A new pilot study by US researchers demonstrates an alternative approach to long-lasting disinfection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by using cationic phenylene ethynylene polymers and oligomers (i.e., conjugated electrolytes). The paper is currently available on medRxiv* preprint server.
Seattle Genetics, Inc. today announced that its phase IIb clinical trial of lintuzumab (SGN-33) in older patients with acute myeloid leukemia (AML) did not meet its primary endpoint of extending overall survival. Lintuzumab is a naked monoclonal antibody that targets the CD33 antigen. As a result of the outcome of this trial, the company will discontinue its development program for lintuzumab.
From a corner office high atop CHI Health Immanuel, a longtime Creighton University researcher is plotting another step along a road he hopes will eventually free diabetic women from osteoporosis, one of many diseases that strike diabetics more forcefully than the general population.
Young persons who use alcohol and/or marijuana experience heightened likelihood of condomless sex, according to a new study published in The American Journal on Addictions. This increased likelihood was greater for women than for men on days with alcohol or marijuana use, each alone but especially when combined.
Merck, known as MSD outside the United States and Canada, announced today that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) unanimously voted to recommend approval of Merck's VYTORIN (ezetimibe/simvastatin) for use in patients with pre-dialysis chronic kidney disease.
› Verified 5 days ago
| Entity Name | American Diagnostics Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639140387 PECOS PAC ID: 1355241274 Enrollment ID: O20170519002150 |
News Archive
A new pilot study by US researchers demonstrates an alternative approach to long-lasting disinfection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by using cationic phenylene ethynylene polymers and oligomers (i.e., conjugated electrolytes). The paper is currently available on medRxiv* preprint server.
Seattle Genetics, Inc. today announced that its phase IIb clinical trial of lintuzumab (SGN-33) in older patients with acute myeloid leukemia (AML) did not meet its primary endpoint of extending overall survival. Lintuzumab is a naked monoclonal antibody that targets the CD33 antigen. As a result of the outcome of this trial, the company will discontinue its development program for lintuzumab.
From a corner office high atop CHI Health Immanuel, a longtime Creighton University researcher is plotting another step along a road he hopes will eventually free diabetic women from osteoporosis, one of many diseases that strike diabetics more forcefully than the general population.
Young persons who use alcohol and/or marijuana experience heightened likelihood of condomless sex, according to a new study published in The American Journal on Addictions. This increased likelihood was greater for women than for men on days with alcohol or marijuana use, each alone but especially when combined.
Merck, known as MSD outside the United States and Canada, announced today that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) unanimously voted to recommend approval of Merck's VYTORIN (ezetimibe/simvastatin) for use in patients with pre-dialysis chronic kidney disease.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Steven D Picerne, MD 1800 W Hibiscus Blvd Ste 100, Melbourne, FL 32901-2624 Ph: (321) 726-3800 | Steven D Picerne, MD 1800 W Hibiscus Blvd Ste 100, Melbourne, FL 32901-2624 Ph: (321) 726-3800 |
News Archive
A new pilot study by US researchers demonstrates an alternative approach to long-lasting disinfection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by using cationic phenylene ethynylene polymers and oligomers (i.e., conjugated electrolytes). The paper is currently available on medRxiv* preprint server.
Seattle Genetics, Inc. today announced that its phase IIb clinical trial of lintuzumab (SGN-33) in older patients with acute myeloid leukemia (AML) did not meet its primary endpoint of extending overall survival. Lintuzumab is a naked monoclonal antibody that targets the CD33 antigen. As a result of the outcome of this trial, the company will discontinue its development program for lintuzumab.
From a corner office high atop CHI Health Immanuel, a longtime Creighton University researcher is plotting another step along a road he hopes will eventually free diabetic women from osteoporosis, one of many diseases that strike diabetics more forcefully than the general population.
Young persons who use alcohol and/or marijuana experience heightened likelihood of condomless sex, according to a new study published in The American Journal on Addictions. This increased likelihood was greater for women than for men on days with alcohol or marijuana use, each alone but especially when combined.
Merck, known as MSD outside the United States and Canada, announced today that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) unanimously voted to recommend approval of Merck's VYTORIN (ezetimibe/simvastatin) for use in patients with pre-dialysis chronic kidney disease.
› Verified 5 days ago
David Samuel Epstein, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1775 W Hibiscus Blvd, Ste 215, Melbourne, FL 32901 Phone: 321-837-3820 | |
Thomas H Magee, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 709 S Harbor City Blvd Ste 100, Melbourne, FL 32901 Phone: 321-409-9900 Fax: 321-309-9033 | |
Dr. Irina S Mezheritskiy, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1350 S Hickory St, Holmes Regional Medical Center/radiology, Melbourne, FL 32901 Phone: 321-434-7313 Fax: 321-434-7238 | |
Dr. Charles Ehlenberger, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1350 Hickory Street, Melbourne, FL 32901 Phone: 321-434-7000 | |
Dr. Santiago Jimenez, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1223 Gateway Dr, Melbourne, FL 32901 Phone: 321-549-0677 | |
Dr. Brent D Brandon, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1350 S Hickory St, Holmes Regional Medical Center/radiology, Melbourne, FL 32901 Phone: 321-434-7313 Fax: 321-434-7238 |